Greenlight laser: a laser for every prostate and every urologist.

World J Urol

Department of Urology, Ospedale Civile Di Guastalla and Ospedale Ercole Franchini Di Montecchio Emilia, Azienda USL-IRCCS Di Reggio Emilia, Via Donatori di Sangue 1, 42016, Guastalla, RE, Italy.

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-020-03499-zDOI Listing

Publication Analysis

Top Keywords

greenlight laser
4
laser laser
4
laser prostate
4
prostate urologist
4
greenlight
1
laser
1
prostate
1
urologist
1

Similar Publications

Objective: To investigate the impact of body mass index (BMI) on preoperative characteristics, lower urinary tract symptoms (LUTS), intraoperative variables, surgical outcomes and postoperative complications.

Methods: This is a retrospective observational study including 891 benign prostate hyperplasia (BPH) patients who underwent GreenLight Laser photoselective vaporization of the prostate (PVP) between 2014 and 2020. Clinical characteristics, uroflowmetry parameters, and surgery related parameters were extracted from electronic health records.

View Article and Find Full Text PDF
Article Synopsis
  • - The study compares the effectiveness of 120 W HPS and 180 W XPS GreenLight laser systems for treating benign prostatic hyperplasia (BPH), revealing that the 180 W system has better operational efficiency and shorter catheterization times.
  • - Eight studies were analyzed, showing that while both systems had similar functional outcomes regarding prostate symptoms and urinary flow, the 180 W system resulted in improved quality of life and lower rates of complications.
  • - The findings suggest that the 180 W XPS laser is a more efficient and safer option for treating BPH, especially in larger prostates, and encourages further randomized trials to verify these results and investigate long-term effects.
View Article and Find Full Text PDF

A 72-year-old high-risk male presented to our hospital with severe bladder outlet obstruction (BOO) caused by an enlarged prostate with a volume exceeding 130 cc. Subsequently, the patient successfully underwent GreenLight laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (PVP). The patient had been unsuitable for conventional surgical modalities such as transurethral resection of the prostate (TURP) or open prostatectomy due to multiple pre-existing comorbidities, including coronary artery disease (CAD), atrial fibrillation (AF), and concurrent use of antiplatelet therapy.

View Article and Find Full Text PDF

Objective Our study was designed to evaluate the postoperative urinary retention (UR) and success rate of the GreenLight Laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (GLL.PVP) procedure for Benign Prostatic Hyperplasia (BPH) patients, both with and without high-risk factors. Methodology We conducted a retrospective follow-up study of postoperative patients who underwent GLL.

View Article and Find Full Text PDF

Objective: Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to surgical BPH treatments.

Methods: Google Trends was used to determine the frequency of searches for different minimally invasive and prostatic ablative treatments for BPH in the United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!